In addition, a novel experiment has been well demonstrated that the ovarian tumor deubiquitinase 1 (OTUD1) alleviates IBD through inhibiting receptor-interacting serine/threonine-protein kinase 1 (RIPK1)-mediated NF-κB activation (139). Here, RIPK1 is linked to irritable bowel syndrome.